The athletes have done the training and achieved their dreams, a trip to the Paris Olympics set to begin Friday July 26th.
Canada’s Solve FSHD provides $1.4m for rare muscle dystrophy therapy – Pharmaceutical Technology
FSHD is a rare genetic disease that results in progressive muscle degeneration, atrophy, and weakness of selected muscles in the body. Image Credit: Allexxandar /